Structure-based design of pyridopyrimidinediones as dipeptidyl peptidase IV inhibitors

Abstract Dipeptidyl peptidase IV (DPP-4) inhibitors have been shown to enhance GLP-1 levels and thereby improve hyperglycemia in type II diabetes. From a small fragment hit, using structure-based design, we have discovered a new class of non-covalent, potent and selective DPP-4 inhibitors.

Gespeichert in:
Autor*in:

Lam, Betty [verfasserIn]

Zhang, Zhiyuan

Stafford, Jeffery A.

Skene, Robert J.

Shi, Lihong

Gwaltney, Stephen L.

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2012

Schlagwörter:

GLP-1

DPP-4

Type II diabetes

Pyridopyrimidinedione

Umfang:

4

Übergeordnetes Werk:

Enthalten in: Feeding European sea bass ( - Torrecillas, S. ELSEVIER, 2018, a Tetrahedron publication for rapid dissemination of preliminary communications on all aspects of bioorganic chemistry, medicinal chemistry, bioinorganic chemistry and related disciplines, Amsterdam [u.a.]

Übergeordnetes Werk:

volume:22 ; year:2012 ; number:21 ; day:1 ; month:11 ; pages:6628-6631 ; extent:4

Links:

Volltext

DOI / URN:

10.1016/j.bmcl.2012.08.110

Katalog-ID:

ELV016395891

Nicht das Richtige dabei?

Schreiben Sie uns!